www.fdanews.com/articles/83026-adams-respiratory-prices-secondary-public-offering
ADAMS RESPIRATORY PRICES SECONDARY PUBLIC OFFERING
December 9, 2005
Adams Respiratory Therapeutics Inc. (ARXT.O: Quote, Profile, Research) on Friday said it has priced its secondary offering of about 5.7 million common shares at $43.75 per share. The company said in a statement the selling stockholders have granted the underwriters an option to purchase up to an additional 849,112 shares to cover over-allotments.